OBJECTIVE: Hashimoto's thyroiditis (HT) is a common autoimmune thyroid disorder that frequently evolves from asymptomatic, T-cell mediated chronic inflammation toward overt hypothyroidism. Previously, we have demonstrated a role for T-bet, a T helper 1/CD8+ T cell transcription factor (TF), and FoxP3, a regulatory T cell TF, in disease progression and severity, but the basis behind their altered mRNA expression remains unknown. In this study, we aimed to leverage the role for microRNAs, representing negative transcriptional regulators, across the spectrum of HT clinical presentations using the same, well-characterized RNA sample cohort. METHOD: Ten hypothyroid, untreated patients (hypoHT), 10 hypothyroid cases rendered euthyroid by l-thyroxine therapy (substHT), 11 spontaneously euthyroid HT subjects (euHT), and 10 healthy controls (ctrl) were probed for three candidate immunoregulatory miRNA (miR-9-5p, miR-29a-3p, and miR-210-3p) using quantitative real-time PCR measurements. Data were normalized to U6snRNA and fold difference in expression calculated by the efficiency corrected 2-ΔΔCt model. RESULTS: Compared to healthy controls, peripheral blood (PB) T cells of HT patients exhibited significantly diminished miR-29a-3p expression levels [median expression levels (IQR), HT vs CTRL, 0.62 (0.44-1.01) vs 1.373 (0.63-2.7), P = 0.046], and a similar, but not significant decline in miR-210-3p abundance [HT vs CTRL, 0.64 (0.39-1.31) vs 1.2 (0.5-2.56), P = 0.24, Wilcoxon test]. A significant inverse correlation was observed between the two differentially expressed transcripts, T-bet mRNA and miR-29a-3p. Moreover, altered miR-29a-3p/T-bet expression in T cells of untreated HT patients was related to low serum FT4, high serum thyrotropin, and decreased thyroid volumes. Of note, miR-210-3p expression was positively correlated to HIF1α, and inversely to FoxP3 mRNA levels, but no evidence of differential expression for any of these miRNA-mRNA pairs was observed. Finally, miR-9-5p expression levels were no different in HT vs control comparisons, or related to clinicopathological features. CONCLUSION: T cell miR-29a-3p is downregulated in HT patients and associated with clinical and biochemical parameters of progressive thyroid injury, plausibly subsequent to altered control of T-bet expression in PB T cells. As such miR-29a-3p/T-bet axis should be further explored as a biomarker or as a plausible target for therapeutic interventions in HT.

Department of Medical Chemistry Biochemistry and Clinical Chemistry Faculty of Medicine University of Osijek Osijek Croatia

Department of Nuclear Medicine and Oncology Faculty of Medicine University of Osijek Osijek Croatia

Department of Pathological Physiology Palacky University and Faculty Hospital Olomouc Czechia

Zobrazit více v PubMed

Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med (2003) 348(26):2646–55. 10.1056/NEJMra021194 PubMed DOI

Shi Y, Wang H, Su Z, Chen J, Xue Y, Wang S, et al. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto’s thyroiditis. Scand J Immunol (2010) 72(3):250–5. 10.1111/j.1365-3083.2010.02425.x PubMed DOI

Tokić S, Štefanić M, Glavaš-Obrovac L, Jaman S, Novosadová E, Petrkova J, et al. The expression of T cell FOXP3 and T-bet is upregulated in severe but not euthyroid Hashimoto’s thyroiditis. Mediators Inflamm (2016) 2016:3687420. 10.1155/2016/368742 PubMed DOI PMC

Figueroa-Vega N, Alfonso-Pérez M, Benedicto I, Sánchez-Madrid F, González-Amaro R, Marazuela M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto’s thyroiditis. J Clin Endocrinol Metab (2010) 95(2):953–62. 10.1210/jc.2009-1719 PubMed DOI

Liu Y, Tang X, Tian J, Zhu C, Peng H, Rui K, et al. Th17/Treg cells imbalance and GITRL profile in patients with Hashimoto’s thyroiditis. Int J Mol Sci (2014) 15(12):21674–86. 10.3390/ijms151221674 PubMed DOI PMC

Li C, Yuan J, Zhu YF, Yang XJ, Wang Q, Xu J, et al. Imbalance of Th17/Treg in different subtypes of autoimmune thyroid diseases. Cell Physiol Biochem (2016) 40(1–2):245–52. 10.1159/000452541 PubMed DOI

Marazuela M, García-López MA, Figueroa-Vega N, de la Fuente H, Alvarado-Sánchez B, Monsiváis-Urenda A, et al. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab (2006) 91(9):3639–46. 10.1210/jc.2005-2337 PubMed DOI

Xue H, Yu X, Ma L, Song S, Li Y, Zhang L, et al. The possible role of CD4 PubMed DOI

Kishore A, Borucka J, Petrkova J, Petrek M. Novel insights into miRNA in lung and heart inflammatory diseases. Med Inflamm (2014) 259131:27. 10.1155/2014/259131 PubMed DOI PMC

Steiner DF, Thomas MF, Hu JK, Yang Z, Babiarz JE, Allen CD, et al. MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells. Immunity (2011) 35(2):169–81. 10.1016/j.immuni.2011.07.009 PubMed DOI PMC

Fayyad-Kazan H, Rouas R, Fayyad-Kazan M, Badran R, El Zein N, Lewalle P, et al. MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function. J Biol Chem (2012) 287(22):18584. 10.1074/jbc.M111.337154 PubMed DOI PMC

Jebbawi F, Fayyad-Kazan H, Merimi M, Lewalle P, Verougstraete J-C, Leo O, et al. A microRNA profile of human CD8 PubMed DOI PMC

Wang H, Flach H, Onizawa M, Wei L, McManus MT, Weiss A. Negative regulation of Hif1a expression and TH17 differentiation by hypoxia regulated miR-210. Nat Immunol (2014) 15(4):393–401. 10.1038/ni.2846 PubMed DOI PMC

Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell (2011) 146(5):772–84. 10.1016/j.cell.2011.07.033 PubMed DOI PMC

Štefanić M, Papić S, Suver M, Glavaš-Obrovac L, Karner I. Association of vitamin D receptor gene 3’ variants with Hashimoto’s thyroiditis in the Croatian population. Int J Immunogenet (2008) 35(2):125–31. 10.1111/j.1744-313X.2008.00748.x PubMed DOI

Tokic S, Štefanić M, Karner I, Glavaš-Obrovac L. Altered expression of CTLA-4, CD28, VDR, and CD45 mRNA in T cells of patients with Hashimoto’s thyroiditis – a pilot study. Endokrynol Pol (2017) 68(3):274–82. 10.5603/EP.2017.0010 PubMed DOI

Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 162:156–9. 10.1006/abio.1987.9999 PubMed DOI

Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 29(9):2002–7. 10.1093/nar/29.9.e45 PubMed DOI PMC

Novosadova E, Chabronova A, Kolek V, Petrek M, Navratilova Z. The serum expression of selected miRNAs in pulmonary sarcoidosis with/without Löfgren’s syndrome. Med Inflamm (2016) 2016:1246129. 10.1155/2016/1246129 PubMed DOI PMC

Jakobs TC, Mentrup B, Schmutzler C, Dreher I, Köhrle J. Proinflammatory cytokines inhibit the expression and function of human type I 5’-deiodinase in HepG2 hepatocarcinoma cells. Eur J Endocrinol (2002) 146(4):559–66. 10.1530/eje.0.1460559 PubMed DOI

Xu G, Tu W, Qin S. The relationship between deiodinase activity and inflammatory responses under the stimulation of uremic toxins. J Transl Med (2014) 12:239. 10.1186/s12967-014-0239-5 PubMed DOI PMC

Gérard AC, Boucquey M, van den Hove MF, Colin IM. Expression of TPO and ThOXs in human thyrocytes is downregulated by IL-1-alpha/IFN-gamma, an effect partially mediated by nitric oxide. Am J Physiol Endocrinol Metab (2006) 291(2):E242–53. 10.1152/ajpendo.00439.2005 PubMed DOI

Marique L, Van Regemorter V, Gérard AC, Craps J, Senou M, Marbaix E, et al. The expression of dual oxidase, thyroid peroxidase, and caveolin-1 differs according to the type of immune response (TH1/TH2) involved in thyroid autoimmune disorders. J Clin Endocrinol Metab (2014) 99(5):1722–32. 10.1210/jc.2013-3469 PubMed DOI

Mazziotti G, Sorvillo F, Naclerio C, Farzati A, Cioffi M, Perna R, et al. Type-1 response in peripheral CD4 and CD8 T cells from patients with Hashimoto’s thyroiditis. Eur J Endocrinol (2003) 148:383–8. 10.1530/eje.0.1480383 PubMed DOI

Karanikas G, Schuetz M, Wahl K, Paul M, Kontur S, Pietschmann P, et al. Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto’s thyroiditis. Clin Endocrinol (Oxf) (2005) 63(2):191–6. 10.1111/j.1365-2265.2005.02324.x PubMed DOI

Bossowski A, Harasymczuk J, Moniuszko A, Bossowska A, Hilczer M, Ratomski K. Cytometric evaluation of intracellular IFN-g and IL-4 levels in thyroid follicular cells from patients with autoimmune thyroid diseases. Thyroid Res (2011) 4:13. 10.1186/1756-6614-4-13 PubMed DOI PMC

Liu Y, You R, Yu N, Gong Y, Qu C, Zhang Y, et al. Increased proportions of Tc17 cells and NK cells may be risk factors for disease progression in Hashimoto’s thyroiditis. Int Immunopharmacol (2016) 40:332–8. 10.1016/j.intimp.2016.09.016 PubMed DOI

Brain O, Owens BM, Pichulik T, Allan P, Khatamzas E, Leslie A, et al. The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release. Immunity (2013) 39(3):521–36. 10.1016/j.immuni.2013.08.035 PubMed DOI

Mikoś H, Mikoś M, Obara-Moszyńska M, Niedziela M. The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD). Endokrynol Pol (2014) 65(2):150–5. 10.5603/EP.2014.0021 PubMed DOI

Kiyici S, Gul OO, Baskan EB, Hacioglu S, Budak F, Erturk E, et al. Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity. Clin Exp Dermatol (2010) 35:603–7. 10.1111/j.1365-2230.2009.03642.x PubMed DOI

Xin A, Masson F, Liao Y, Preston S, Guan T, Gloury R, et al. A molecular threshold for effector CD8+ T cell differentiation controlled by transcription factors Blimp-1 and T-bet. Nat Immunol (2016) 17:422–32. 10.1038/ni.3410 PubMed DOI PMC

Kallies A, Xin A, Belz GT, Nutt SL. Blimp-1 transcription factor is required for the differentiation of effector CD8+ T cells and memory responses. Immunity (2009) 31:283–95. 10.1016/j.immuni.2009.06.021 PubMed DOI

Luo J, Niu X, Zhang M, Zhang K, Chen M, Deng S. Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus. Autoimmunity (2015) 48(2):80–6. 10.3109/08916934.2014.976627 PubMed DOI PMC

Boulet S, Daudelin J-F, Labrecque N. IL-2 induction of Blimp-1 is a key in vivo signal for CD8+ short-lived effector T cell differentiation. J Immunol (2014) 193(4):1847–54. 10.4049/jimmunol.1302365 PubMed DOI

Lazarevic V, Chen X, Shim J-H, Hwang ES, Jang E, Bolm AN, et al. T-bet represses TH17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt. Nat Immunol (2016) 12:96–104. 10.1038/ni.1969 PubMed DOI PMC

Wang Y, Godec J, Ben-Aissa K, Cui K, Zhao K, Pucsek AB, et al. The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-γ-producing T helper 17 cells. Immunity (2014) 40(3):355–66. 10.1016/j.immuni.2014.01.002 PubMed DOI PMC

Teteloshvili N, Smigielska-Czepiel K, Kroesen BJ, Brouwer E, Kluiver J, Boots AM, et al. T-cell activation induces dynamic changes in miRNA expression patterns in CD4 and CD8 T-cell subsets. Microrna (2015) 4(2):117–22. 10.2174/2211536604666150819194636 PubMed DOI

Haoquan W, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, et al. miRNA profiling of naïve, effector and memory CD8 T cells. PLoS One (2007) 2(10):e1020. 10.1371/journal.pone.0001020 PubMed DOI PMC

Lai X, Wolkenhauer O, Vera J. Understanding microRNA-mediated gene regulatory networks through mathematical modelling. Nucleic Acids Res (2016) 44(13):6019–35. 10.1093/nar/gkw550 PubMed DOI PMC

Ferreira RC, Simons HZ, Thompson WS, Rainbow DB, Yang X, Cutler AJ, et al. Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent 2 in autoimmunity. J Autoimmun (2017) 84:75–86. 10.1101/134692 PubMed DOI PMC